Suchergebnisse - "KRUPKA CHRISTINA"

PubPharm (4)

1

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells

enthalten in: Oncoimmunology | 2018

von Braciak, T. | Roskopf, C. | Wildenhain, S. | +14

2

Recent developments in immunotherapy of acute myeloid leukemia

enthalten in: Journal of hematology & oncology | 2017

von Lichtenegger, F. | Krupka, C. | Haubner, S. | +2

3

Recent developments in immunotherapy of acute myeloid leukemia

enthalten in: Journal of hematology & oncology | 2017

von Lichtenegger, F. | Krupka, C. | Haubner, S. | +2

4

Targeting CD157 in AML using a novel, Fc-engineered antibody construct

enthalten in: Oncotarget | 2017

von Krupka, C. | Lichtenegger, F. | Köhnke, T. | +14

1
[1]